BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15826291)

  • 1. [Missing granulocytic infiltrate in pityriasis versicolor--indication of specific anti-inflammatory activity of the pathogen?].
    Wroblewski N; Bär S; Mayser P
    Mycoses; 2005; 48 Suppl 1():66-71. PubMed ID: 15826291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malassezia yeasts and pityriasis versicolor.
    Crespo-Erchiga V; Florencio VD
    Curr Opin Infect Dis; 2006 Apr; 19(2):139-47. PubMed ID: 16514338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Malassezia species from Tunisian patients with pityriasis versicolor.
    Trabelsi S; Oueslati J; Fekih N; Kammoun MR; Khaled S
    Tunis Med; 2010 Feb; 88(2):85-7. PubMed ID: 20415164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pityriasis versicolor alba.
    Thoma W; Krämer HJ; Mayser P
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):147-52. PubMed ID: 15752280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultivation and pathogenicity of Malassezia furfur with special respect to mycological studies on etiological fungus of tinea (pityriasis) versicolor.
    Lii SL
    Tokushima J Exp Med; 1969 Dec; 16(3):127-51. PubMed ID: 5382447
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin diseases associated with Malassezia species in humans. Clinical features and diagnostic criteria.
    Difonzo EM; Faggi E
    Parassitologia; 2008 Jun; 50(1-2):69-71. PubMed ID: 18693561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pityriasis versicolor and the yeasts of genus Malassezia].
    Crespo-Erchiga V; Gómez-Moyano E; Crespo M
    Actas Dermosifiliogr; 2008 Dec; 99(10):764-71. PubMed ID: 19091214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of pityriasis versicolor in Adana, Turkey.
    Karakaş M; Turaç-Biçer A; Ilkit M; Durdu M; Seydaoğlu G
    J Dermatol; 2009 Jul; 36(7):377-82. PubMed ID: 19583685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of barrier function in dermatophytosis and pityriasis versicolor.
    Lee WJ; Kim JY; Song CH; Jung HD; Lee SJ; Kim DW
    J Dermatol; 2011 Nov; 38(11):1049-1053. PubMed ID: 21950511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study.
    Kurutas EB; Ozturk P
    Mycoses; 2016 Nov; 59(11):720-725. PubMed ID: 27329971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncommon cases of pityriasis versicolor.
    Romano C
    Parassitologia; 2008 Jun; 50(1-2):93-4. PubMed ID: 18693567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characterization in situ of inflammatory cells in pityriasis (tinea) versicolor.
    Scheynius A; Faergemann J; Forsum U; Sjöberg O
    Acta Derm Venereol; 1984; 64(6):473-9. PubMed ID: 6084917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor.
    Prohic A; Ozegovic L
    Mycoses; 2007 Jan; 50(1):58-63. PubMed ID: 17302750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada.
    Gupta AK; Kohli Y; Faergemann J; Summerbell RC
    Med Mycol; 2001 Apr; 39(2):199-206. PubMed ID: 11346269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malassezia furfur in a case of generalized pityriasis versicolor].
    Krzewicka L
    Przegl Dermatol; 1974; 61(1):55-9. PubMed ID: 4847381
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of Malassezia yeast species isolated from patients with pityriasis versicolor.
    Petry V; Tanhausen F; Weiss L; Milan T; Mezzari A; Weber MB
    An Bras Dermatol; 2011; 86(4):803-6. PubMed ID: 21987156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls.
    Ashbee HR; Fruin A; Holland KT; Cunliffe WJ; Ingham E
    Exp Dermatol; 1994 Oct; 3(5):227-33. PubMed ID: 7881768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.
    Köse O; Bülent Taştan H; Riza Gür A; Kurumlu Z
    J Dermatolog Treat; 2002 Jun; 13(2):77-9. PubMed ID: 12060506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey.
    Rodoplu G; Saracli MA; Gümral R; Taner Yildiran S
    J Mycol Med; 2014 Jun; 24(2):117-23. PubMed ID: 24746716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malassezia yeast species isolated from patients with dermatologic lesions.
    Rincón S; Celis A; Sopó L; Motta A; Cepero de García MC
    Biomedica; 2005 Jun; 25(2):189-95. PubMed ID: 16022373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.